| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/09/2009 | WO2009086097A1 Intraocular irrigating solutions comprising histidine and methods for treating corneal edema |
| 07/09/2009 | WO2009085847A1 Tetrahydroindoles having sphingosine-1-phosphate receptor activity |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084044A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
| 07/09/2009 | WO2009083768A2 Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions |
| 07/09/2009 | WO2009083621A1 Method for the production and purification of the factor derived from the pigmented epithelium of the retina in a yeast system |
| 07/09/2009 | WO2009083188A2 Compositions and methods for prophylaxis and treatment of cellular degenerative disorders |
| 07/09/2009 | WO2009067407A3 Compositions of matrix metalloproteinase activating endopeptidases for reducing intraocular pressure, and methods of use thereof |
| 07/09/2009 | WO2009058958A3 Lipoxin a4 protection for cornea endothelial cells |
| 07/09/2009 | WO2007112675A8 Vegf receptor fusion protein and use thereof |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 07/09/2009 | US20090175930 Composition Suppressing The Expression of Target Gene in Eyeball and Medicament For Treating of Disease in Eyeball |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175875 Molecules and Methods for Modulating Complement Component |
| 07/09/2009 | CA2710388A1 Treatment of abnormal or excessive scars |
| 07/08/2009 | EP2077108A1 Use of an NMDA receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity |
| 07/08/2009 | EP1765785B1 Prostaglandin analogs |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009082039A1 Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009080268A1 Pharmaceutical for the treatment of phantom phenomena |
| 07/02/2009 | WO2009061811A8 Substituted cyclopentanes having prostaglanding activity |
| 07/02/2009 | WO2009047640A3 Method for treating and/or preventing photoreceptor damage in retina |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170944 Ophthalmic micellar compositions with enhanced stability |
| 07/02/2009 | US20090170887 Novel indazole derivative having spiro ring structure in side chain |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170811 Composition for treatment of a detached retina and method of prodution thereof |
| 07/02/2009 | US20090170780 Protection of the retina against laser injury by nap and related peptides |
| 07/02/2009 | US20090169629 Micellar compositions with ophthalmic applications |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169556 Vascular endothelial cell growth factor antagonists |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075000A1 Combination of azelastine and ciclesonide |
| 07/01/2009 | EP2074994A1 Enhanced ocular neuroprotection/neurostimulation |
| 07/01/2009 | EP2074142A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 07/01/2009 | EP2073800A2 Ophthalmic compositions comprising diglycine |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1418864A4 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1322316B1 Diuretic or sulphonylurea for use in antiviral treatment |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506232C Composition for use in treatment of ocular hypertension and glaucoma |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553845 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/25/2009 | WO2009079635A1 Interfering rna delivery system and uses thereof |
| 06/25/2009 | WO2009079544A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009077736A2 A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist |
| 06/25/2009 | WO2009032267A3 Contact lens based bioactive agent delivery system |
| 06/25/2009 | US20090163596 Bimatoprost crystalline form I |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits |
| 06/25/2009 | US20090163550 Retinoid-containing sustained release intraocular implants and related methods |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090162358 Antigen binding proteins |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | DE102007063210A1 Arzneimittel zur Behandlung von Phantomphänomenen Drugs for treatment of phantom phenomena |
| 06/25/2009 | CA2747095A1 Optical correction |
| 06/25/2009 | CA2709579A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072051A1 Combination of azelastine and mometasone |
| 06/24/2009 | EP2072047A1 Therapeutic agent for opthalmic disease |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1324767B1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |